ACC Analytic Center

American College of Cardiology Analytic Center: ICD & CathPCI Registries


In Press:

Kaiser DW, Tsai V, Heidenreich PA, Goldstein MK, Wang Y, Curtis JP, Yang Y, Turakhia MP. Defibrillator Implantations for Primary Prevention in the United States: Inappropriate Care or Inadequate Documentation? Insights from the National Cardiovascular Data ICD Registry. HRJ. In Press. (accepted 5/7/15). 

Heidenreich PA, Tsai V, Bao H, Curtis JP, Goldstein MK, Curtis L, Hernandez A, Peterson PN, Masoudi FA. Cardiac Resynchronization Therapy in the Elderly.  JACC: HF.  


Russo AM, Daugherty SL, Masoudi FA, Wang, Y, Curtis J, Lampert R. Gender and Outcomes Following Primary Prevention ICD Implantation: Findings From the NCDR®. Am Heart J. Published online April 23, 2015.

Cavender MA, Joynt KE, Parzynski CS, Resnic FS, Rumsfeld JS, Moscucci M, Masoudi FA, Curtis JP, Peterson ED and Gurm HS. State Mandated Public Reporting and Outcomes of Percutaneous Coronary Intervention in the United States. The American journal of cardiology. 2015.
Zusterzeel R, Spatz ES, Curtis JP, Sanders WE, Selzman KA, Pina IL, Bao H, Ponirakis A, Varosy PD, Masoudi FA, Canos DA and Strauss DG. Cardiac resynchronization therapy in women versus men: observational comparative effectiveness study from the National Cardiovascular Data Registry. Circulation Cardiovascular quality and outcomes. 2015;8:S4-11.

Heidenreich PA, Tsai V, Curtis JP, Wang Y, Turakhia M, Masoudi FA, Varosy PD, Goldstein MK. A Validated Risk Model for One-Year Mortality after Primary Prevention Implantable Cardioverter Defibrillator Placement. Am Heart J. 2015. Published online January 6, 2015.

Ghanbari H, Nallamothu BK, Wang Y and Curtis JP. Antithrombotic therapy and outcomes after ICD implantation in patients with atrial fibrillation and coronary artery disease: an analysis from the National Cardiovascular Data Registry (NCDR)(R). Journal of the American Heart Association. 2015;4.

Nallamothu BK, Normand SL, Wang Y, Hofer TP, Brush JE, Jr., Messenger JC, Bradley EH, Rumsfeld JS and Krumholz HM. Relation between door-to-balloon times and mortality after primary percutaneous coronary intervention over time: a retrospective study. Lancet. 2015;385:1114-22.

Hsu JC, Varosy PD, Parzynski CS, Chaudhry SI, Dewland TA, Curtis JP and Marcus GM. Procedure timing as a predictor of inhospital adverse outcomes from implantable cardioverter-defibrillator implantation: insights from the National Cardiovascular Data Registry. American heart journal. 2015;169:45-52.e3.

Jordan CP, Freedenberg V, Wang Y, Curtis JP, Gleva MJ and Berul CI. Implant and clinical characteristics for pediatric and congenital heart patients in the national cardiovascular data registry implantable cardioverter defibrillator registry. Circulation Arrhythmia and electrophysiology. 2014;7:1092-100.

Zusterzeel R, Curtis JP, Canos DA, Sanders WE, Selzman KA, Pina IL, Spatz ES, Bao H, Ponirakis A, Varosy PD, Masoudi FA and Strauss DG. Sex-specific mortality risk by QRS morphology and duration in patients receiving CRT: results from the NCDR. Journal of the American College of Cardiology. 2014;64:887-94.

Bagai A, Wang Y, Wang TY, Curtis JP, Gurm HS, Shah B, Cheema AN, Peterson ED, Saucedo JF, Granger CB, Roe MT, Bhatt DL, McNamara RL and Alexander KP. In-hospital switching between clopidogrel and prasugrel among patients with acute myocardial infarction treated with percutaneous coronary intervention: insights into contemporary practice from the national cardiovascular data registry. Circulation Cardiovascular interventions. 2014;7:585-93.

Borne RT, Peterson PN, Greenlee R, Heidenreich PA, Wang Y, Curtis J, Tzou W, Varosy PD, Masoudi FA. Temporal Trends in Patient Characteristics and Outcomes Among Medicare Beneficiaries Undergoing Primary Prevention Implantable Cardioverter-Defibrillator Placement in the United States: 2006-2010 Results from the NCDR®.  Circ Cardiovasc Qual Outcomes. 2014;.114.008653

Prutkin JM, Reynolds MR, Bao H, Curtis JP, Al-Khatib SM, Aggarwal S, Uslan DZ. Rates of and Factors Associated with Infection in 200,909 Medicare Implantable Cardioverter-Defibrillator Implants: Results from the NCDR®Circulation. 2014;114.009081

Hsu JC, Marcus GM, Al-Khatib SM, Wang Y, Curtis JP, Sood N, Parker MW, Kluger J, Lampert R, Russo AM. Predictors of an Inadequate Defibrillation Safety Margin at Implantable Cardioverter-Defibrillator Implantation: Insights from the NCDR®.   J Am Coll Cardiol. 2014;64:256–64.

Steckman DA, Varosy PD, Parzynski CS, Masoudi FA, Curtis JP, Sauer WH, Nguyen DT. In-hospital complications associated with reoperations of implantable cardioverter defibrillators. Am J Cardiol. 2014; Aug 1;114(3):419-26

Bradley MS, Rao SV, Curtis JP, Parzynski CS, Messenger JC, Daugherty SL, Rumsfeld JS, Gurm HS. Change in Hospital-Level Use of Transradial Percutaneous Coronary Intervention and Periprocedural OutcomesCirc Cardiovasc Qual Outcomes. 2014; Jun 4. pii: CIRCOUTCOMES.114.001020

Schneider PM, Pellegrini CN, Wang Y, Fein AS, Reynolds MR, Curtis JP, Masoudi FA, Varosy PD. Prevalence of guideline-directed medical therapy among patients receiving cardiac resynchronization therapy defibrillator implantation in the National Cardiovascular Data Registry during the years 2006 to 2008. Am J Cardiol. 2014; Jun 15;113(12):2052-6.

Lichtman JH, Wang Y, Jones SB, Leifheit-Limson EC, Shaw LJ, Vaccarino V, Rumsfeld JS, Krumholz HM, Curtis JP. Age and sex differences in inhospital complication rates and mortality after percutaneous coronary intervention procedures: evidence from the NCDR(®). Am Heart J. 2014; Mar;167(3):376-83

Dodson JA, Reynolds MR, Bao H, Al-Khatib SM, Peterson ED, Kremers MS, Mirro MJ, Curtis JP. 2013. Developing a Risk Model for in-Hospital Adverse Events following ICD Implantation: A Report from the NCDR® RegistryJ Am Coll Cardiol. 2014; Mar 4;63(8):788-96.

Sherwood MW, Wang Y, Curtis JP, Peterson ED, Rao SV.  Patterns and outcomes of red blood cell transfusion in patients undergoing percutaneous coronary intervention.   JAMA. 2014; Feb 26;311(8):836-43

Dodson JA, Lampert R, Wang Y, Hammill SC, Varosy P, Curtis JP. 2013. Temporal Trends in Measures of Quality of Care: The Impact of the NCDR Registry.   Circulation. 2014; Feb 4;129(5):580-6

Dev S, Peterson PN, Wang Y, Curtis JP, Varosy P, Masoudi FA. 2013. Prevalence, Correlates, and Temporal Trends in Antiarrhythmic Drug Use at Discharge after ICD Placement: Findings from the NCDRAm J Cardiol. 2014; Jan 15;113(2):314-20.

Russo AM, Wang Y, Al-Khatib SM, Curtis JP, Lampert R. 2013. Patient, physician, and procedural factors Influencing the Use of Defibrillation Testing During Initial Implantable Cardioverter Defibrillator Insertion: Findings From the NCDR®Pacing Clin Electrophysiol. 2013; Dec;36(12):1522-31.

Fazel R, Curtis J, Wang Y, Einstein AJ, Smith-Bindman R, Tsai TT, Chen J, Shah ND, Krumholz HM, Nallamothu BK. 2013. Determinants of Fluoroscopy Time for Invasive Coronary Angiography and Percutaneous Coronary Intervention: Insights from the NCDR®Catheter Cardiovasc Interv. 2013; Dec 1;82(7):1091-105.

Kontos MC, Wang Y, Chaudhry SI, Vetrovec GW, Curtis J, Messenger J. 2013. Lower Hospital Volume is Associated with Higher In-Hospital Mortality in Patients Undergoing Primary PCI for ST Elevation MI: A Report from the NCDR. Circ Cardiovasc Qual Outcomes. 2013; Nov;6(6):659-67

Akar JG, Bao H, Jones P, Wang Y, Chaudhry SI, Varosy P, Masoudi FA, Stein K, Saxon LA, Curtis JP. Use of Remote Monitoring of Implantable Cardiac Defibrillators: insights from the Patient RElated Determinants of ICD Remote Monitoring (PREDICt RM) study. Circulation. 2013; Nov 26;128(22):2372-83

Menees DS, Peterson ED, Rumsfeld JS, Curtis JP, Wang Y, Messenger JC, Gurm HS. Door to Balloon Time and Mortality Among Patients Undergoing Primary PCI.   N Engl J Med. 2013;Sep 5;369-(10):901-9.

Hsu JC, Varosy PD, Bao H, Dewland TA, Curtis JP, Marcus GM. Cardiac Perforation from Implantable Cardioverter-Defibrillator Lead Placement: Insights from the NCDR. Circ Cardiovasc Qual Outcomes. 2013;Sep 1;6(5):582-90.

Lampert R, Wang Y, Curtis JS. Variation among hospitals in selection of higher-cost, "higher-tech", implantable cardioverter-defibrillators: Data from the NCDR ICD RegistryAHJ. 2013; Jun;165(6):1015-1023.

Peterson PN, Varosy PD, Heidenreich PA, Wang Y, Dewland TA, Curtis JP, Go AS, Greenlee RT, Magid DJ, Normand SLT, Masoudi FA. Association of Single vs. Dual Chamber ICDs with Mortality, Readmissions and Complications among Patients Receiving an ICD for Primary PreventionJAMA. 2013;May 15;309(19):2025-34.

Kremers MS, Hammill SC, Berul CI, Koutras C, Curtis JS, Wang Y, Beachy J, Blum Meisnere L, Conyers DM, Reynolds MR, Heidenreich PA, Al-Khatib SM, Pina IL, Blake K, Norine Walsh M, Wilkoff BL, Shalaby A, Masoudi FA, Rumsfeld J. The National ICD Registry Report: Version 2.1 including leads and pediatrics for years 2010 and 2011Heart Rhythm. 2013; Volume 10, Issue 4, Pages e59–e65.

Hsu JC, Varosy PD, Bao H, Wang Y, Curtis JP, Marcus, GM.  Low Body Mass Index but Not Obesity is Associated with In-Hospital Adverse Events and Mortality Among Implantable Cardioverter-Defibrillator Recipients: Insights from the NCDR®J. Am Heart Assoc. 2012; Dec;1(6):e003863.

Farmer SA, Tuohy EJ, Small DS, Wang Y, Groeneveld PW. Are Racial/Ethnic Gaps in the Use of Cardiac Resynchronization Therapy Narrowing? An Analysis of 107,096 Patients from the NCDR ICD Registry™.   Circ Cardiovasc Qual Outcomes. 2012;Nov;5(6):798-807.

Eapen ZJ, Al-Khatib S, Lopes RD, Wang Y, Bao H, Curtis JP, Heidenreich PA, Hernandez AF. Are Racial/Ethnic Gaps in the Use of Cardiac Resynchronization Therapy Narrowing? An Analysis of 107,096 Patients from the NCDR ICD Registry™J Am Coll Cardiol. 2012;Oct 16;60(16):1577-8.

Curtis JP, Geary LL, Wang Y, Chen J, Drye ED, Grosso LM, Spertus JA, Rumsfeld JS, Weintraub WS, Masoudi FA, Brindis RG, Krumholz HM. Development of Two Registry-based Measures Suitable for Characterizing Hospital Performance on 30-day All-Cause Mortality Rates Among Patients Undergoing PCI.  Circ Cardiovasc Qual Outcomes. 2012;Sep 1;5(5):628-37.

Cheng, A, Wang Y, Berger RD, Calkins H, Buxton AE, Curtis JP, Lampert R. Electrophysiology Studies in Patients Undergoing ICD Implantation: Findings from the NCDR®.   Pacing Clin Electrophysiol. 2012;Aug;35(8):912-8.

Bhatt P, Curtis J, Wang Y, Lampert R. Impact of the Recent Lead Recall on Utilization of Implantable Cardioverter Defibrillators:  Data from the NCDR ICD Registry™.   J Cardiovasc Electrophysiol. 2012;Aug;23(8):861-5.

Tavris DR, Wang Y, Jacobs S, Gallauresi B, Curtis JP, Messenger J, Resnic FS, Fitzgerald S. Bleeding and Vascular Complications at the Femoral Access Site following Percutaneous Coronary Intervention (PCI): An Evaluation of Hemostatis StrategiesJ Invasive Cardiol. 2012;Jul;24(7):328-34

Matlock DD, Peterson PN, Wang Y, Curtis JP, Reynolds MR, Varosy PD, Masoudi FA. Variation in use of dual-chamber implantable cardioverter-defibrillators: results from the national cardiovascular data registry.   Arch Int Med. 2012;Apr 23; 172(8); 634-641.

Miller AL, Wang Y, Curtis J, Masoudi FA, Buxton AE, Wang TY. Optimal medical therapy use among patients receiving implantable cardioverter-defibrillators: Insights from the NCDR®.   Arch Intern Med. 2012;Jan 9; 172(1);64-7.

Curtis JP, Rathore SS, Wang Y, Chen J, Nallamothu BK, Krumholz HM. Use and Effectiveness of Intra-Aortic Balloon Pumps Among Patients Undergoing High Risk Percutaneous Coronary Intervention: Insights from the CATHPCI Registry.   Circ Cardiovasc Qual Outcomes. 2012; Jan;5;21-30.

Freeman JV, Wang Y, Curtis JP, Heidenreich PA, Hlatky MA. Physician Procedure Volume and Complications of Cardioverter-Defibrillator ImplantationCirculation. 2012;Jan 3;125(1):57-64.

Tsai V, Goldstein MK, Hsia HH, Wang Y, Curtis J, Heidenreich PA. Age differences in primary prevention implantable cardioverter-defibrillator use in U.S. individualsJ Am Geriatr Soc. 2011; Sep;59(9):1589-95.

Tsai V, Goldstein MK, Hsia HH, Wang Y, Curtis J, Heidenreich PA. Influence of age on perioperative complications among patients undergoing implantable cardioverter-defibrillators for primary prevention in the United StatesCirc Cardiovasc Qual Outcomes. 2011; Sep;4(5):549-56.

Dewland TA, Pellegrini CN, Wang Y, Marcus GM, Keung E, Varosy PD. Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registryJ Am Coll Cardiol. 2011; Aug 30;58(10):1007-13.

Dodson JA, Wang Y, Chaudhry SI, Curtis JP. Bleeding-avoidance strategies and outcomes in patients ≥80 years of age with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the NCDR CathPCI Registry). Am J Cardiol. 2012; Jul 1;110(1):1-6.

Haines DE, Wang Y, Curtis J. Implantable cardioverter-defibrillator registry risk score models for acute procedural complications or death after implantable cardioverter-defibrillator implantation. Circulation. 2011; May 17;123(19):2069-76.

Wei S, Loyo-Berríos NI, Haigney MC, Cheng H, Pinnow EE, Mitchell KR, Beachy JH, Woodward AM, Wang Y, Curtis JP, Marinac-Dabic D. Elevated B-type natriuretic peptide is associated with increased in-hospital mortality or cardiac arrest in patients undergoing implantable cardioverter-defibrillator implantation. Circ Cardiovasc Qual Outcomes. 2011;May;4(3):346-54.

Matlock DD, Kutner JS, Emsermann CB, Al-Khatib SM, Sanders GD, Dickinson LM, Rumsfeld JS, Davidson AJ, Crane LA, Masoudi FA. Regional variations in physicians' attitudes and recommendations surrounding implantable cardioverter-defibrillators  .J Card Fail. 2011; Apr;17(4):318-24.

Matlock, DD, Peterson PN, Heidenreich PA, Lucas FL, Malenka DJ, Wang Y, Curtis JP, Kutner JS, Fisher ES, and Masoudi FA. Variation in use of dual-chamber implantable cardioverter-defibrillators: results from the national cardiovascular data registry.  Circ Cardiovasc Qual Outcomes. 2011;Jan 1; 4(1): 114-21.

Cheng A, Wang Y, Curtis JP, Varosy PD. Acute lead dislodgements and in-hospital mortality in patients enrolled in the national cardiovascular data registry implantable cardioverter defibrillator registryJ Am Coll Cardiol.  2010;Nov 9; 56(20): 1651-6.

Freeman JV, Wang Y, Curtis JP, Heidenreich PA, Hlatky MA. The relation between hospital procedure volume and complications of cardioverter-defibrillator implantation from the implantable cardioverter-defibrillator registry.  J Am Coll Cardiol. 2010;Sep 28;56(14): 1133-9.

Hammill SC, Kremers MS, Stevenson LW, Heidenreich PA, Lang CM, Curtis JP, Wang Y, Berul CI, Kadish AH, Al-Khatib SM, Pina IL, Walsh MN, Mirro MJ, Lindsay BD, Reynolds MR, Pontzer K, Blum L, Masoudi F, Rumsfeld J, Brindis RG. Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure.  Heart Rhythm. 2010;Sep;7(9):1340-5.

Fein AS, Wang Y, Curtis JP, Masoudi FA, Varosy PD, Reynolds MR. Prevalence and predictors of off-label use of cardiac resynchronization therapy in patients enrolled in the National Cardiovascular Data Registry Implantable Cardiac-Defibrillator RegistryJ Am Coll Cardiol. 2010;Aug 31;56(10): 766-73.

Aggarwal A, Wang Y, Rumsfeld JS, Curtis JP, Heidenreich PA. Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantationHeart Rhythm . 2009;Nov;6(11):1565-71. Epub 2009 Aug 5.

Hammill SC, Kremers MS, Kadish AH, Stevenson LW, Heidenreich PA, Lindsay BD, Mirro MJ, Radford MJ, McKay C, Wang Y, Lang CM, Pontzer K, Rumsfeld J, Phurrough SE, Curtis JP, Brindis RG. Review of the ICD Registry's third year, expansion to include lead data and pediatric ICD procedures, and role for measuring performance. Heart Rhythm. 2009; Sep;6(9):1397-401.

Daugherty SL, Peterson PN, Wang Y, Curtis JP, Heidenreich PA, Lindenfeld J, Vidaillet HJ, Masoudi FA. Use of implantable cardioverter defibrillators for primary prevention in the community: do women and men equally meet trial enrollment criteria?  Am Heart J. 2009;Aug;158(2):224-9.

Rathore SS, Curtis JP, Chen J, Wang Y, Nallamothu BK, Epstein AJ, Krumholz HM. Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myocardial infarction: national cohort study.  BMJ. 2009;May 19;338:b1807.

Curtis JP, Luebbert JJ, Wang Y, Rathore SS, Chen J, Heidenreich PA, Hammill SC, Lampert RI, Krumholz HM. Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator. JAMA. 2009;Apr 22; 301(16): 1661-70.

Farmer SA, Kirkpatrick JN, Heidenreich JA, Curtis JP, Wang Y, Groeneveld PW. Ethnic and racial disparities in cardiac resynchronization therapy. Heart Rhythm. 2009;Mar;6(3):325-31.

Peterson PN, Daugherty SL, Wang Y, Vidaillet HJ, Heidenreich PA, Curtis JP, Masoudi FA. Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapyCirculation. 2009; Mar 3;119(8):1078-84.

Hammill SC, Kremers MS, Stevenson LW, Kadish AH, Heidenreich PA, Lindsay BD, Mirro MJ, Radford MJ, Wang Y, Curtis JP, Lang CM, Harder JC, Brindis RG. Review of the Registry's second year, data collected, and plans to add lead and pediatric ICD procedures. Heart Rhythm. 2008;Sep;5(9):1359-63.

Chakrabarti A, Krumholz HM, Wang Y, Rumsfeld JS, Nallamothu BK. Time-to-reperfusion in patients undergoing interhospital transfer for primary percutaneous coronary intervention in the U.S: an analysis of 2005 and 2006 data from the National Cardiovascular Data Registry.  J Am Coll Cardiol. 2008;Jun 24;51(25):2442-2443.

Nallamothu BK, Wang Y, Bradley EH,Ho KKL, Curtis JC, Rumsfeld JS, Masoudi FA, Krumholz HM. Comparing hospital performance in door-to-balloon time between the Hospital Quality Alliance and the National Cardiovascular Data RegistryJ Am Coll Cardiol. 2007;Oct 9;50(15):1517-1519.

Hammill SC, Stevenson LW, Kadish AH, Kremers MS, Heidenreich PA, Lindsay BD, Mirro MJ, Radford MJ, Wang Y, Lang CM, Harder JC, Brindis RG. Review of the registry's first year, data collected, and future plans. Heart Rhythm. 2007;Sep; 4(9): 1260-3.